Cleared Special

K133968 - WONDFO MULTI-DRUG URINE TEST CUP, PANEL

K133968 is an FDA 510(k) clearance for WONDFO MULTI-DRUG URINE TEST CUP, manufactured by Guangzhou Wondfo Biotech Co., Ltd.. The device is a Class 2 Chemistry device with product code DKZ cleared through the Special 510(k) pathway after a 61-day FDA review.

K133968 · Guangzhou Wondfo Biotech Co., Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2014
Decision
61d
Days
Class 2
Risk

K133968 is an FDA 510(k) clearance for the WONDFO MULTI-DRUG URINE TEST CUP, PANEL. Classified as Enzyme Immunoassay, Amphetamine (product code DKZ), Class II - Special Controls.

Submitted by Guangzhou Wondfo Biotech Co., Ltd. (Gaithersburg, US). The FDA issued a Cleared decision on February 25, 2014 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.3100 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Guangzhou Wondfo Biotech Co., Ltd. devices

FDA 510(k) Submission Details - K133968

510(k) Number K133968 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2013
Decision Date February 25, 2014
Days to Decision 61 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d faster than avg
Panel avg: 88d · This submission: 61d
Pathway characteristics
Modification to existing cleared device.

DKZ Device Classification - Class 2, Special Controls

Product Code DKZ Enzyme Immunoassay, Amphetamine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DKZ Enzyme Immunoassay, Amphetamine

All 208
Devices cleared under the same product code (DKZ) and FDA review panel - the closest regulatory comparables to K133968.
CR3 KEYLESS SPLIT SAMPLE CUP AMPHETAMINE-COCAINE
K141532 · Guangzhou Wondfo Biotech Co., Ltd. · Jul 2014
QUICKSCREEN AMPHETINE 500 TEST
K131069 · Phamatech, Inc. · May 2014
UCP MULTI-DRUG TEST KEY CUPS
K132812 · Ucp Biosciences, Inc. · Mar 2014
LZI ORAL FLUID AMPHETAMINE ENZYME IMMUNOASSAY, CALIBRATORS, CONTROLS
K131653 · Lin-Zhi International, Inc. · Feb 2014
ONE STEP SINGLE/MULTI-DRUG TEST CUP
K131110 · Co-Innovation Biotech Co., Ltd. · Jan 2014
GENPRIME DRUGS OF ABUSE READER SYSTEM
K130082 · Genprime, Inc. · Dec 2013